Heart imaging study for Kawasaki disease
Part of Blood & lymphatic, Heart & circulation, Skin clinical trials.
This study uses heart imaging to better understand Kawasaki disease. It may help doctors assess heart health in affected children and teenagers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child has been diagnosed with Kawasaki disease according to standard guidelines.
- You or your child is 18 years old or younger.
- You or your child does not have a history of congenital heart disease or cardiomyopathy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses magnetic resonance imaging (MRI) to look at blood flow to the heart muscle during stress in children with certain heart conditions. It may help doctors better understand how the heart is working.
This study looks at children with Kawasaki disease, a condition that causes inflammation in blood vessels. The goal is to learn more about how it affects kids in Europe and North India.
This study uses artificial intelligence to look at chest X-rays to help doctors find Kawasaki disease earlier. It may lead to faster treatment and better outcomes for children.
This trial tests whether a cholesterol-lowering medication called atorvastatin can help children whose hearts were damaged by Kawasaki disease (a serious childhood illness that inflames blood vessels). The study may help reduce long-term heart complications.
This study looks at Kawasaki disease that gets complicated by a serious immune reaction called macrophage activation syndrome (MAS). It aims to better understand and treat this complication in children.
This trial is testing a way to match children with Kawasaki disease to the best treatment. It looks at specific symptoms and fever duration to see if a child qualifies for the study, which may help doctors give the right treatment faster.
Hear when a new Kawasaki Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.